Delivery Order SPE2DB20D1100-SPE2DB24FC4A6
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $3,392.60 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of May 15, 2025. The contract is a Firm Fixed Price (FFP) arrangement and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam, 100 grams, with a ceiling value of $1,811.64 and a period of performance through June 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Clindamycin Phosphate 1% Foam, 100 grams, with a ceiling value of $1,217.44 and a performance period through June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565379228 - Clindamycin Phosphate 1% Foam, 100 grams. The contract has a ceiling value of $3,459.25 and an ultimate completion date of August 8, 2024. This contract is not set aside for any specific business classification. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous Indefinite...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560408677 - Clindamycin Phosphate 1% Foam 50GM, with a ceiling value of $2,433.39 and a completion date of March 29, 2023. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a $1,354.58 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,166,349 units of Clindamycin Phosphate 1% Foam, a prescription pharmaceutical product. The order has a completion date of July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) by the DLA and other agencies to provide a wide range of medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4558478384 - Clindamycin Phosphate 1% Foam, 100 gm, with a ceiling value of $1,339.74 and a completion date of September 16, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FD8C6, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The award, with a ceiling value of $1,036.56, is for the delivery of Clindamycin Phosphate 1% Lotion, a prescription medication, with an ultimate completion date of September 16, 2024. This appears to be a delivery order contract, with a firm fixed-price pricing type, and is not set aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.13 delivery order contract is for the supply of 4559304324 - Clindamycin PH 1% Gel 30GM, with a completion date of December 8, 2022. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...